Patent RE39591 was granted and assigned to Abbott on April, 2007 by the United States Patent and Trademark Office.
Antimicrobial compounds having the formulaas well as pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.